MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN Società MERCK Kommanditgesellschaft auf Aktien Other OTC
Azioni
MKKGY
US5893392093
Prodotti farmaceutici
Attività
- soluzioni e prodotti per la ricerca scientifica e biotecnologica (44,2%);
- prodotti farmaceutici (38,4%): farmaci da prescrizione per il trattamento di diabete, cancro, sclerosi multipla, infertilità, malattie cardiovascolari, disturbi del sistema nervoso centrale, disturbi infiammatori, ecc;
- materiali ad alte prestazioni per l'industria elettronica (17,4%): materiali semiconduttori, cristalli liquidi, pigmenti e additivi, materiali organici a base di carbonio, ecc.
Le vendite nette sono distribuite geograficamente come segue: Germania (4,8%), Europa (24%), Cina (12,9%), Asia/Pacifico (20,1%), Stati Uniti (26,8%), Nord America (1,6%), America Latina (6,3%), Medio Oriente e Africa (3,5%).
Vendite per attività
| EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Life Science
44,2
%
| 10 380 | 46,7 % | 9 281 | 44,2 % | -10,59% |
Healthcare
38,4
%
| 7 839 | 35,3 % | 8 053 | 38,4 % | +2,73% |
Electronics
17,4
%
| 4 013 | 18,1 % | 3 659 | 17,4 % | -8,82% |
Vendite per regione
| EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
28,2
%
| 6 302 | 28,3 % | 5 911 | 28,2 % | -6,20% |
Europe
21,0
%
| 4 524 | 20,3 % | 4 402 | 21,0 % | -2,70% |
Asia Pacific
19,9
%
| 4 479 | 20,1 % | 4 181 | 19,9 % | -6,65% |
China
11,8
%
| 2 818 | 12,7 % | 2 477 | 11,8 % | -12,10% |
Germany
6,8
%
| 1 532 | 6,9 % | 1 420 | 6,8 % | -7,31% |
Latin America
6,0
%
| 1 175 | 5,3 % | 1 267 | 6,0 % | +7,83% |
Middle East and Africa
2,5
%
| 516 | 2,3 % | 535 | 2,5 % | +3,68% |
Switzerland
2,4
%
| 592 | 2,7 % | 512 | 2,4 % | -13,51% |
North America
1,4
%
| 294 | 1,3 % | 287 | 1,4 % | -2,38% |
Dirigenti
| Dirigenti | Titolo | Età | Da |
|---|---|---|---|
| Chief Executive Officer | 62 | 13/07/20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01/08/14 |
| Director of Finance/CFO | 54 | 26/04/19 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/20 |
Constantin Fest
IRC | Investor Relations Contact | - | - |
Jeff White
PRN | Corporate Officer/Principal | - | - |
Andrew Paterson
SAM | Sales & Marketing | - | - |
| Corporate Officer/Principal | - | 01/09/21 | |
Hong Chow
PRN | Corporate Officer/Principal | 53 | 01/01/21 |
Amministratori
| Amministratori | Titolo | Età | Da |
|---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
| Chairman | 67 | 26/04/19 | |
Gabriele Eismann
BRD | Director/Board Member | 62 | 01/01/91 |
Dietmar Oeter
BRD | Director/Board Member | 57 | 01/01/95 |
Barbara Lambert
BRD | Director/Board Member | 62 | 11/08/23 |
Renate Koehler
BRD | Director/Board Member | - | 26/04/19 |
| Director/Board Member | - | 26/04/19 | |
Daniel Thelen
BRD | Director/Board Member | - | 26/04/19 |
Simon Thelen
BRD | Director/Board Member | 44 | 26/04/19 |
Birgit Biermann
BRD | Director/Board Member | 50 | 14/07/22 |
Classe di azioni
| Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
|---|---|---|---|---|---|
| Azione A | 1 | 305 535 626 | 0 | 0 | 29,71 % |
| Azione B | 1 | 129 242 252 | 129 159 619 ( 99,94 %) | 0 |
Partecipazioni
| Nome | Azioni | % | Valorizzazione |
|---|---|---|---|
| 2 787 509 | 4.43% | 113 340 116 $ | |
PT MERCK TBK 86.65% | 388 194 920 | 86.65% | 96 272 340 $ |
VERA THERAPEUTICS, INC. 3.48% | 1 913 501 | 3.48% | 72 693 903 $ |
PRECIGEN, INC. 8.18% | 20 647 152 | 8.18% | 28 906 013 $ |
Coordinate società
Società del gruppo
| Nome | Categoria e settore |
|---|---|
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. |
Miscellaneous Commercial Services
|
Pharmaceuticals: Major
| |
Ares Trading SA
| |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. |
Medical Specialties
|
AZ Electronic Materials (Japan) KK
 AZ Electronic Materials (Japan) KK Chemicals: SpecialtyProcess Industries AZ Electronic Materials (Japan) KK manufactures plastic materials and inorganic chemicals. The company is located in Tokyo, Japan |
Chemicals: Specialty
|
Merck Santé SASU
 Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. |
Pharmaceuticals: Major
|
Merck Financial Services GmbH
 Merck Financial Services GmbH Finance/Rental/LeasingFinance Part of Merck KGaA, Merck Financial Services GmbH provides financing operations and activities. The company is based in Darmstadt, Germany. The CEOs are Jörg Bermüller, Rando Bruns. The German company was founded in 2007. |
Finance/Rental/Leasing
|
Millipore SAS
 Millipore SAS Electronic Equipment/InstrumentsElectronic Technology Founded in 1972, Millipore SAS is a subsidiary of Merck KGaA that provides industrial instruments for measurement. The company is based in Molsheim, France. |
Electronic Equipment/Instruments
|
Merck Life Science A/S
 Merck Life Science A/S Electronic Equipment/InstrumentsElectronic Technology Part of Merck KGaA, Merck Life Science A/S is a Danish company that provides industrial instruments for measurement. The company is located in Denmark. |
Electronic Equipment/Instruments
|
Settore
Vendite per attività
Vendite per regione
| Variaz. 1 gen. | Capi. | |
|---|---|---|
| +15,93% | 9,07 Mrd | |
| +49,51% | 4,68 Mrd | |
| -20,82% | 4,53 Mrd | |
| +8,58% | 4,06 Mrd | |
| -25,68% | 2,21 Mrd | |
| +8,35% | 2,19 Mrd | |
| +10,42% | 2 Mrd | |
| -41,65% | 1,82 Mrd | |
| -0,50% | 1,64 Mrd |
